missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Gibco™ Human C5a, Animal-Free Recombinant Protein, PeproTech®
Recombinant Protein
$339.00 - $5010.00
Specifications
| Accession Number | P01031 |
|---|---|
| For Use With (Application) | Functional Assay |
| Formulation | protein with no preservative |
| Gene ID (Entrez) | 727 |
| Molecular Weight (g/mol) | 8.3 kDa |
| Catalog Number | Mfr. No. | Quantity | Price | Quantity | |||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number | Mfr. No. | Quantity | Price | Quantity | |||||
AF30070100
|
Gibco™
AF30070100UG |
100 μg |
Each for $1,038.00
|
|
|||||
AF300701MG
|
Gibco™
AF300701MG |
1 mg |
Each for $5,010.00
|
|
|||||
AF3007020UG
|
Gibco™
AF3007020UG |
20 μg |
Each for $339.00
|
|
|||||
AF30070500
|
Gibco™
AF30070500UG |
500 μg |
Each for $3,005.00
|
|
|||||
Description
Recombinant Human C5a is an 8.3 kDa glycoprotein containing the 74 amino acid residues of the C5a anaphylatoxin chain. This product is shipped at ambient temperature. For storage, handling and reconstitution information, please see the lot-specific Certificate of Analysis
The protein encoded by this gene is the fifth component of complement, which plays an important role in inflammatory and cell killing processes. This protein is comprised of alpha and beta polypeptide chains that are linked by a disulfide bridge. An activation peptide, C5a, which is an anaphylatoxin that possesses potent spasmogenic and chemotactic activity, is derived from the alpha polypeptide via cleavage with a convertase. The C5b macromolecular cleavage product can form a complex with the C6 complement component, and this complex is the basis for formation of the membrane attack complex, which includes additional complement components. Mutations in this gene cause complement component 5 deficiency, a disease where patients show a propensity for severe recurrent infections. Defects in this gene have also been linked to a susceptibility to liver fibrosis and to rheumatoid arthritis.Specifications
| P01031 | |
| protein with no preservative | |
| 8.3 kDa | |
| E. coli | |
| <0.1 EU/ μg | |
| Complement C5a | |
| Measured by its ability to support adhesion of Human Umbilical Vein Endothelial Cells (HUVEC) to the Recombinant Human C5a-coated surface. | |
| Recombinant | |
| -20°C | |
| Lyophilized |
| Functional Assay | |
| 727 | |
| Human C5a, Animal-Free | |
| RUO | |
| anaphylatoxin; anaphylatoxin C5a analog; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4; C4B1; C4B12; C4B2; C4B3; C4B5; C4F; C5; C5a; C5a anaphylatoxin; C5b; C5D; CH; CO4; complement C5; Complement C5 alpha chain; Complement C5 alpha' chain; Complement C5 beta chain; complement component 5; CPAMD3; CPAMD4; DADB-112B14.11; ECLZB; FLJ17816; FLJ17822; FLJ60561; Hc; He; Hemolytic complement; MGC142298; MGC164979; prepro-C5; RGD1561905 | |
| C5 | |
| Unconjugated | |
| TLQKKIEEIA AKYKHSVVKK CCYDGACVNN DETCEQRAAR ISLGPRCIKA FTECCVVASQ LRANISHKDM QLGR | |
| E. coli | |
| ≥ 98% by SDS-PAGE gel and HPLC analyses. |